Thermo Fisher Scientific Boosts US Investment by $2 Billion

Thermo Fisher Scientific, a global leader in serving science, has announced a significant expansion plan involving a $2 billion investment in the United States over the next four years. This initiative aims to bolster American innovation, manufacturing, and economic competitiveness within the life sciences sector, reinforcing the United States’ position as an epicenter of scientific advancement.

As one of the world’s foremost manufacturers in the pharmaceutical sector, Thermo Fisher Scientific plays a pivotal role in facilitating biopharma companies’ efforts to develop and produce medicines domestically. This substantial investment underscores Thermo Fisher’s commitment to supporting a robust U.S. healthcare supply chain and is expected to generate a ripple effect, favorably impacting the broader American economy. With operations currently spanning 64 manufacturing sites across 37 states, the company plans to enhance its capacity further by creating high-paying jobs and increasing its investment in research and development, which already exceeds $1 billion annually. This initiative not only demonstrates Thermo Fisher’s confidence in the US as a leader in scientific innovation but also its dedication to sustaining growth and fostering a stronger industry foundation.